methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate has been researched along with a 63162 in 1 studies
Studies (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Trials (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Recent Studies (post-2010) (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) |
---|---|---|---|---|---|
16 | 0 | 0 | 31 | 0 | 0 |
Protein | Taxonomy | methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate (IC50) | a 63162 (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.3475 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cathcart, MK; Folcik, VA | 1 |
1 other study(ies) available for methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and a 63162
Article | Year |
---|---|
Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation.
Topics: Acetamides; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Benzyl Compounds; Humans; Hydroxamic Acids; In Vitro Techniques; Lipoproteins, LDL; Lipoxygenase Inhibitors; Monocytes; Naphthoquinones; ortho-Aminobenzoates; Oxidation-Reduction; Phenyl Ethers | 1993 |